Literature DB >> 10364014

Genotypes of Helicobacter pylori obtained from gastric ulcer patients taking or not taking NSAIDs.

L Li1, L K Kelly, K Ayub, D Y Graham, M F Go.   

Abstract

OBJECTIVE: Whether Helicobacter pylori infection and use of nonsteroidal antiinflammatory drugs (NSAIDs) are independent risk factors for ulcerogenesis remains unclear. We undertook this study to evaluate H. pylori isolates from gastric ulcer patients to determine whether the genotype of the infecting isolate could be correlated with the use or nonuse of NSAIDs.
METHODS: Fifty-two patients presenting with gastric ulcer and infected with H. pylori were included; 26 patients were taking NSAIDs or aspirin (ASA) regularly at the time of ulcer diagnosis. Polymerase chain reaction (PCR) was employed to assess the presence and mosaicism of the following H. pylori genes: cagA, vacA, iceA, and picB.
RESULTS: We found no statistical differences in the presence of these genes in H. pylori isolates from gastric ulcer patients taking or not taking prescription NSAIDs or ASA. A 297-bp fragment of the cagA gene was detected in 96% of the isolates from the NSAID and ASA users and 100% from the non-NSAID users (p = 1.0). A larger and more variable region of the cagA gene was detected more frequently among the isolates from non-NSAID users than those from NSAID users (p = 0.05). Ninety-two percent of the isolates were identified as vacA genotype s1. The dominant vacA subtype was s1b, 76.9% and 65.4% in isolates from non-NSAID-taking or NSAID-taking patients, respectively (p = 0.4). iceA1 genotype was not correlated with gastric ulcer as this allele was only detected in 17.3% of all isolates.
CONCLUSIONS: No significant differences in the presence of the candidate virulence genes vacA, cagA, picB, or iceA were detected in isolates from gastric ulcer patients taking prescription NSAIDs or ASA, compared with those not taking these drugs, indicating that single gene presence does not allow discrimination of isolates that may be important in NSAID-induced ulcerogenesis. A variable region of the cagA gene was more frequently detected in isolates from patients not taking NSAIDs or ASA, suggesting that this gene may be modified by NSAID- or ASA-related factors or that certain strains may be selected for in patients taking these medications.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364014     DOI: 10.1111/j.1572-0241.1999.01133.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  6 in total

1.  Genomic fingerprinting and genotyping of Helicobacter pylori strains from patients with duodenal ulcer or gastric cancer from different geographic regions.

Authors:  Li Li; David Y Graham; Oscar Gutierrez; Jong G Kim; Robert M Genta; Hala M T El-Zimaity; Mae F Go
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

2.  Genotypic, clinical, and demographic characteristics of children infected with Helicobacter pylori.

Authors:  B D Gold; L J van Doorn; J Guarner; M Owens; D Pierce-Smith; Q Song; L Hutwagner; P M Sherman; O L de Mola; S J Czinn
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

3.  Persisting and Increasing Neutrophil Infiltration Associates with Gastric Carcinogenesis and E-cadherin Downregulation.

Authors:  Hualin Fu; Yue Ma; Meng Yang; Chunlei Zhang; Hai Huang; Ying Xia; Lungen Lu; Weilin Jin; Daxiang Cui
Journal:  Sci Rep       Date:  2016-07-14       Impact factor: 4.379

4.  Effects of Multi-Strain Probiotics on Immune Responses and Metabolic Balance in Helicobacter pylori-Infected Mice.

Authors:  Chun-Che Lin; Wei-Chiao Huang; Chiu-Hsian Su; Wei-De Lin; Wen-Tzu Wu; Bi Yu; Yuan-Man Hsu
Journal:  Nutrients       Date:  2020-08-17       Impact factor: 5.717

5.  Antagonistic Activities of Lactobacillus rhamnosus JB3 Against Helicobacter pylori Infection Through Lipid Raft Formation.

Authors:  Anh Duy Do; Chiu-Hsian Su; Yuan-Man Hsu
Journal:  Front Immunol       Date:  2022-01-14       Impact factor: 7.561

6.  Eudesmin attenuates Helicobacter pylori-induced epithelial autophagy and apoptosis and leads to eradication of H. pylori infection.

Authors:  Jai-Sing Yang; Chao-Min Wang; Chiu-Hsian Su; Han-Chen Ho; Chiung-Hung Chang; Chang-Hung Chou; Yuan-Man Hsu
Journal:  Exp Ther Med       Date:  2018-01-04       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.